Loading...
•
Sep 30, 2022
ResMed Q1 2023 Earnings Report
ResMed's first quarter of fiscal year 2023 demonstrated revenue growth and solid performance.
Key Takeaways
ResMed Inc. reported a 5% increase in revenue to $950.3 million, with a diluted earnings per share of $1.43 and non-GAAP diluted earnings per share of $1.51.
Revenue increased by 5% to $950.3 million; up 9% on a constant currency basis.
Gross margin expanded by 90 bps to 56.9%; non-GAAP gross margin expanded by 40 bps to 57.6%.
Income from operations increased 5%; non-GAAP operating profit up 4%.
Diluted earnings per share of $1.43; non-GAAP diluted earnings per share of $1.51.
Revenue by Geographic Location
Forward Guidance
No forward guidance was provided in the press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...